Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
NCT: NCT04427384 · RECRUITING
NCT IDNCT04427384
StatusRECRUITING
Start Date2020-09-11
Completion2028-12-31
SponsorGT Medical Technologies, Inc. (INDUSTRY)
First posted
Last updated
Brief Summary
The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.
Frequently Asked Questions
What is Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)?
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) is a clinical trial registered under NCT04427384. Current status: RECRUITING.
What is the status of NCT04427384?
The current status of NCT04427384 (Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)) is: RECRUITING.
When did Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) start?
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) started on 2020-09-11.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.